Financier | Commitments |
---|---|
IDA Credit | 48.00 |
International Bank for Reconstruction and Development | 252.00 |
P164453
Closed
Patricia Alvarez
Plurinational State of Bolivia
February 14, 2018
(as of board presentation)
June 14, 2018
March 21, 2019
US$ 300.00 million
Ministry of Health - Agencia de Infraestructura en Salud y Equipamiento Medico (AISEM),Ministry of Health
2018
US$ 300.00 million
B
Not Applicable
January 31, 2024
Yes
BANK APPROVED
May 21, 2024
Financier | Commitments |
---|---|
IDA Credit | 48.00 |
International Bank for Reconstruction and Development | 252.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | 252.00 |
IDA Commitment | 48.00 |
IBRD + IDA Commitment | 300.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 300.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Apr 15, 2022 | IBRD-88680 | Int Charges | 2,991.38 |
Apr 15, 2022 | IBRD-88680 | Int Charges | 16,662.09 |
Apr 15, 2022 | IBRD-88680 | Int Charges | 158,166.50 |
Apr 15, 2022 | IBRD-88680 | Int Charges | 986,773.30 |
Jun 29, 2022 | IBRD-88680 | Loan Disb | 6,358,491.00 |
Jun 17, 2021 | IBRD-88680 | Loan Disb | 3,033,788.80 |
Jul 20, 2021 | IBRD-88680 | Loan Disb | 2,635,941.00 |
Jul 2, 2021 | IBRD-88680 | Loan Disb | 3,218,624.80 |
May 27, 2021 | IBRD-88680 | Loan Disb | 1,242,077.90 |
Oct 15, 2021 | IBRD-88680 | Int Charges | 751,061.70 |
Oct 15, 2021 | IDA-62480 | Int Charges | 56,880.42 |
Oct 15, 2021 | IDA-62480 | Int Charges | 21,575.70 |
Sep 7, 2021 | IBRD-88680 | Loan Disb | 5,000,000.00 |
Aug 5, 2021 | IBRD-88680 | Loan Disb | 2,911,942.50 |
Oct 15, 2021 | IBRD-88680 | Int Charges | 617.26 |
Jun 14, 2018 | IDA-62480 | Loan Commitment | 48,000,000.00 |
Jun 14, 2018 | IBRD-88680 | Loan Commitment | 252,000,000.00 |
Apr 15, 2024 | IDA-62480 | Int Charges | 95,668.35 |
Apr 15, 2024 | IBRD-88680 | Int Charges | 7,889.40 |
Apr 15, 2024 | IBRD-88680 | Int Charges | 4,528,410.50 |
Apr 15, 2024 | IDA-62480 | Int Charges | 2,797.39 |
Oct 24, 2023 | IBRD-88680 | Loan Cancel | 127,983,704.00 |
Oct 24, 2023 | IDA-62480 | Loan Cancel | 45,380,000.00 |
Oct 15, 2023 | IBRD-88680 | Int Charges | 160,417.92 |
Oct 15, 2023 | IBRD-88680 | Int Charges | 4,230,092.50 |
Oct 15, 2023 | IDA-62480 | Int Charges | 56,880.42 |
Oct 15, 2023 | IDA-62480 | Int Charges | 89,366.02 |
Apr 15, 2023 | IBRD-88680 | Int Charges | 153,425.56 |
Apr 15, 2023 | IBRD-88680 | Int Charges | 3,871,538.00 |
Apr 15, 2020 | IDA-62480 | Int Charges | 56,791.24 |
Apr 15, 2020 | IDA-62480 | Int Charges | 45,015.97 |
Apr 20, 2020 | IBRD-88680 | Loan Disb | 11,943,652.00 |
Apr 15, 2020 | IBRD-88680 | Int Charges | 122,505.28 |
Apr 15, 2020 | IBRD-88680 | Int Charges | 303,877.10 |
Apr 15, 2020 | IBRD-88680 | Int Charges | 462.33 |
Apr 15, 2020 | IBRD-88680 | Int Charges | 7,093.92 |
May 7, 2020 | IBRD-88680 | Loan Disb | 5,809,074.00 |
Oct 15, 2020 | IDA-62480 | Int Charges | 35,027.22 |
Aug 6, 2020 | IBRD-88680 | Loan Disb | 1,635,146.80 |
Dec 23, 2020 | IBRD-88680 | Loan Disb | 1,697,055.20 |
Jan 4, 2021 | IBRD-88680 | Loan Disb | 242,711.38 |
Dec 31, 2020 | IBRD-88680 | Loan Disb | -2,471,825.20 |
Oct 15, 2022 | IBRD-88680 | Int Charges | 146,112.95 |
Oct 15, 2022 | IBRD-88680 | Int Charges | 2,030,870.80 |
Apr 15, 2023 | IDA-62480 | Int Charges | 56,569.60 |
Apr 15, 2023 | IDA-62480 | Int Charges | 78,678.60 |
Dec 21, 2021 | IBRD-88680 | Loan Disb | 1,170,855.60 |
Dec 16, 2022 | IBRD-88680 | Loan Disb | -14,401,625.00 |
Oct 15, 2022 | IDA-62480 | Int Charges | 39,289.08 |
Oct 15, 2022 | IDA-62480 | Int Charges | 56,880.42 |
Dec 13, 2021 | IBRD-88680 | Loan Disb | 4,465,668.50 |
May 5, 2022 | IBRD-88680 | Loan Disb | 3,504,310.00 |
Apr 15, 2022 | IDA-62480 | Int Charges | 56,569.60 |
Apr 15, 2022 | IDA-62480 | Int Charges | 20,663.07 |
Jul 14, 2020 | IBRD-88680 | Loan Disb | 25,000,000.00 |
Oct 15, 2019 | IBRD-88680 | Int Charges | 1,881.25 |
Oct 15, 2019 | IBRD-88680 | Int Charges | 311,203.50 |
Oct 15, 2019 | IBRD-88680 | Int Charges | 68,598.43 |
Oct 15, 2019 | IDA-62480 | Int Charges | 358.33 |
Oct 15, 2019 | IDA-62480 | Int Charges | 57,993.42 |
Oct 15, 2019 | IDA-62480 | Int Charges | 35,481.90 |
Oct 15, 2019 | IBRD-88680 | Int Charges | 96,549.66 |
Oct 15, 2019 | IDA-62480 | Int Charges | 18,390.41 |
Sep 18, 2019 | IBRD-88680 | Loan Disb | 2,500,000.00 |
Mar 26, 2020 | IBRD-88680 | Loan Disb | 18,796,640.00 |
Mar 21, 2019 | IDA-62480 | Fee Charges | 120,000.00 |
Mar 21, 2019 | IBRD-88680 | Loan Disb | 630,000.00 |
Mar 21, 2019 | IBRD-88680 | Fee Charges | 630,000.00 |
Jun 19, 2019 | IBRD-88680 | Loan Disb | 3,500,000.00 |
Jun 19, 2019 | IDA-62480 | Loan Disb | 2,500,000.00 |
Apr 29, 2019 | IBRD-88680 | Loan Disb | 500,000.00 |
Mar 21, 2019 | IDA-62480 | Loan Disb | 120,000.00 |
Oct 15, 2021 | IBRD-88680 | Int Charges | 3,513.29 |
Oct 15, 2021 | IBRD-88680 | Int Charges | 198,554.80 |
Sep 30, 2021 | IBRD-88680 | Loan Disb | 5,840,053.00 |
Aug 26, 2021 | IBRD-88680 | Loan Disb | 3,182,859.00 |
Oct 20, 2021 | IBRD-88680 | Loan Disb | 4,128,576.50 |
Nov 23, 2021 | IBRD-88680 | Loan Disb | 6,737,858.00 |
Feb 26, 2021 | IBRD-88680 | Loan Disb | 1,837,962.40 |
Feb 4, 2021 | IBRD-88680 | Loan Disb | 3,304,270.80 |
Dec 11, 2020 | IBRD-88680 | Loan Disb | 3,020,766.50 |
Jun 11, 2021 | IBRD-88680 | Loan Disb | 3,079,951.20 |
Apr 13, 2021 | IBRD-88680 | Loan Disb | 949,361.40 |
Apr 15, 2021 | IBRD-88680 | Int Charges | 217,978.97 |
Apr 15, 2021 | IBRD-88680 | Int Charges | 637,591.20 |
Apr 15, 2021 | IDA-62480 | Int Charges | 56,503.36 |
Apr 15, 2021 | IDA-62480 | Int Charges | 21,855.17 |
Jul 20, 2020 | IBRD-88680 | Loan Disb | 3,012,112.20 |
Oct 15, 2020 | IBRD-88680 | Int Charges | 32,728.06 |
Oct 15, 2020 | IBRD-88680 | Int Charges | 241,502.66 |
Oct 15, 2020 | IBRD-88680 | Int Charges | 767,618.10 |
Oct 15, 2020 | IBRD-88680 | Int Charges | 2,567.85 |
Oct 15, 2020 | IDA-62480 | Int Charges | 56,396.23 |
Name | Review | Date |
---|---|---|
Procurement | Moderately Satisfactory | 2023-09-28 |
Project Management | Moderately Unsatisfactory | 2023-09-28 |
Overall Implementation Progress (IP) | Moderately Unsatisfactory | 2023-09-28 |
Progress towards achievement of PDO | Moderately Unsatisfactory | 2023-09-28 |
Financial Management | Moderately Unsatisfactory | 2023-09-28 |
Monitoring and Evaluation | Satisfactory | 2023-09-28 |
INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: 08-01-2024 |
---|---|
Outcomes | |
Risk to Development Outcome | |
Bank Performance | |
Borrower Performance | |
Government Performance | |
Implementing Agency |
INDICATOR | ICR REVIEW: 12-16-2024 | PROJECT PERFORMANCE ASSESSMENT REPORT: |
---|---|---|
Outcome Rating | Unsatisfactory | N/a |
Risk To Development Outcome | N/a | |
Bank Performance | Unsatisfactory | N/a |
Borrower Performance | N/a | |
Government Performance | N/a | |
Implementing Agency | N/a | |
Icr Quality | High | N/a |
M&e Quality | Modest | N/a |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Health facilities of targeted networks aplying updated clinic health standards (normas de atención clínica) | Value | 0.00 | 0.00 | 50.00 |
Date | May 31, 2018 | April 18, 2024 | May 20, 2024 | |
Comment |
Number of diagnosed cases treated per approved COVID-19 protocol | Value | 0.00 | 55349.00 | 15000.00 |
Date | March 30, 2020 | April 18, 2024 | December 31, 2023 | |
Comment |
Network referral centers operational with at least 60% of the required medical staff and providing health services | Value | 0.00 | 0.00 | 0.00 |
Date | June 28, 2018 | April 18, 2024 | ||
Comment |
Doctors checking the MoH clinical guidelines application at least once in the last 60 days | Value | 0.00 | 0.00 | 0.00 |
Date | June 28, 2018 | January 30, 2024 | ||
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Medical specialists enrolled in residency program supported by the project | Value | 0.00 | 0.00 | 300.00 |
Date | May 31, 2018 | April 18, 2024 | March 29, 2024 | |
Comment |
Number of health facilities equipped to improve response to COVID-19 outbreak | Value | 0.00 | 286.00 | 0.00 |
Date | March 10, 2020 | April 18, 2024 | ||
Comment |
Grievance Redress Mechanism (GRM) designed and operational available to attend in indigenous languages of the region | Value | No | Yes | Yes |
Date | May 31, 2018 | April 18, 2024 | ||
Comment |
Healthcare professionales graduated from health diploma programs | Value | 0.00 | 150.00 | 0.00 |
Date | May 31, 2018 | April 18, 2024 | ||
Comment |
Number of regional laboratories equipped to improve response to COVID-19 outbreak | Value | 0.00 | 3.00 | 0.00 |
Date | March 10, 2020 | April 18, 2024 | ||
Comment |
Patients reporting being satisfied with health services provided in the targeted networks desagregated by gender (including LGBTI) and self- ethnic identification | Value | 0.00 | 0.00 | 0.00 |
Date | May 31, 2018 | April 18, 2024 | ||
Comment |
Female patients reporting being satisfied with health services provided in the targeted networks | Value | 0.00 | 0.00 | 0.00 |
Date | May 31, 2018 | April 18, 2024 | ||
Comment |
New hospitals equipped | Value | 0.00 | 0.00 | 0.00 |
Date | June 28, 2018 | April 18, 2024 | ||
Comment |
Number of clinical guidelines updated, approved by the MoHS and officially disseminated | Value | 0.00 | 6.00 | 7.00 |
Date | May 31, 2018 | April 18, 2024 | July 31, 2024 | |
Comment |
New hospitals that do not use incineration to treat hospital waste in the targeted networks | Value | 0.00 | 0.00 | 0.00 |
Date | June 28, 2018 | April 18, 2024 | ||
Comment |